This is a preliminary report of the dramatic response obtained by intra-and sublesional treatment of oral lichen planus with triamcinolone acetonide in aqueous suspension (Kenalog Parenteralg). Although the initial series (7 patients) is small and the intermediate and long-term effects are not yet known, the immediate beneficial results have been startling. It is hoped that similar responses may be obtained for obscure oral inflammatory entities such as erythema multiforme, pemphigoid lesions, psoriasis and others of "unknown etiology."
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Although the etiology of lichen planus is unknown, it has been suggested that patients exhibiting oral manifestations of this disease may be categorized as nervous, anxious, or emotionally distressed. Whatever the etiology, there has been little progress towards a cure or even significant relief of the varying symptomatology. Although some oral lesions are painless, others are uncomfortable, irritating, or "burning." Bullae often cause severe pain, especially when ruptured, leaving raw, bleeding, sensitive denuded areas. Unsuccessful attempts to alleviate these manifestations many times have produced cancerophobia, compounding the emotional problems.
Past treatment regimens for oral lichen planus have been relatively ineffective. Topical applications of synthetic corticosteroids recently have been the vogue, and although early reports were encouraging, later results did not support the initial enthusiasm.
Because of the effectiveness of triamcinolone acetonide aqueous suspension for many dermatologic entities, intra-and sublesional injections of several oral lichen planus lesions were carried out with obvious, dramatic response. Each lesion was given one dose of approximately 0.5 cc. (5 mg.) injected in fractional amounts at various points in the lesion. Larger lesions were given slightly more, 0.7 cc. (7 mg.). There was little to no discomfort following the injections. After 72 hours, examination of the lesions showed 45% to 50%o involution with corresponding relief of symptoms. In three cases the entire lesion disappeared in two weeks. In the other four cases with larger lesions, approximately 10%o to 15%o of the lesion remained, but the patients were completely symptom free. It Kenalogg injection for oral lichen planus I SLEEPER
SUMMARY
To date there has been no satisfactory treatment for oral lichen planus. The intralesional and sublesional injection of triamcinolone acetonide aqueous suspension has produced short-term, dramatic results enhancing the prospect of effective management of this disease.
